Cargando…
Safety of Antithymocyte Globulin Use in Kidney Graft Recipients During the COVID-19 Pandemic
BACKGROUND: There are many safety concerns regarding the use of antithymocyte globulin (ATG) in kidney transplant recipients (KTRs) during the ongoing COVID-19 pandemic. Hereby, we present our recent experience with ATG administration both as induction therapy and as an anti-rejection treatment. MAT...
Autores principales: | Kolonko, Aureliusz, Więcek, Andrzej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556699/ https://www.ncbi.nlm.nih.gov/pubmed/34697282 http://dx.doi.org/10.12659/AOT.933001 |
Ejemplares similares
-
Which Kidney Transplant Recipients Can Benefit from the Initial Tacrolimus Dose Reduction?
por: Krzyżowska, Kinga, et al.
Publicado: (2018) -
A Review of Induction with Rabbit Antithymocyte Globulin in Pediatric Heart Transplant Recipients
por: Schweiger, Martin, et al.
Publicado: (2018) -
Antithymocyte globulin-induced refractory hypotension in renal transplantation recipient
por: Rafat, Shamim, et al.
Publicado: (2017) -
Potential Utility of Neutrophil-to-Lymphocyte, Platelet-to-Lymphocyte, and Neutrophil, Lymphocyte, and Platelet Ratios in Differential Diagnosis of Kidney Transplant Acute Rejection: A Retrospective, Propensity Score Matched Analysis
por: Kolonko, Aureliusz, et al.
Publicado: (2022) -
Poor Patient and Graft Outcome After Induction Treatment by Antithymocyte Globulin in Recipients of a Kidney Graft After Nonrenal Organ Transplantation
por: Mai, Hoa Le, et al.
Publicado: (2018)